| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $168.9M | +99.4% |
| Cost of Revenue | $97.4M | +124.8% |
| R&D Expense | $98.3M | +39.3% |
| SG&A Expense | $82.2M | +54.3% |
| Operating Income | -$23.3M | +93.2% |
| Pre-tax Income | -$9.3M | +97.4% |
| Income Tax | $4.7M | +151.2% |
| Net Income | -$14.0M | +96.0% |
| EPS (Basic) | -$0.03 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.5M | +25.3% |
| Current Assets | $329.1M | +28.8% |
| Total Assets | $688.2M | +24.2% |
| Current Liabilities | $71.7M | +5.9% |
| Total Liabilities | $224.4M | -39.6% |
| Stockholders' Equity | $463.8M | +153.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.2M | +9.8% |
| Capital Expenditures | $902K | +40.9% |
| Investing Cash Flow | -$59.5M | -381.0% |
| Financing Cash Flow | $208.1M | -1.3% |
| Free Cash Flow | -$99.1M | +9.5% |
| +97.1% |
| EPS (Diluted) | -$0.28 | +73.1% |